Q32 Bio Inc. Deferred Tax Assets, Net of Valuation Allowance
Q32 Bio Inc. (FIXX) had Deferred Tax Assets, Net of Valuation Allowance of $2.80 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $2.80M.
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $1.76M; Deferred Tax Assets, Net of Valuation Allowance as first filed $0.00.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2025-12-31 | $2.80M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $1.76M 10-K · filed 2026-03-10 | $0.00 10-K · filed 2025-03-11 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-11 |